Explore more publications!
Healthcare Journal of Oregon
Got News to Share?

Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on April 13, 2026

Wellness Industry Reaches $6.8 Trillion, Driving Demand for Skilled Professionals
16 hours ago

Wellness Industry Reaches $6.8 Trillion, Driving Demand for Skilled Professionals

Indeterminate EIN Presswire
Biomerica Reports Third Quarter Fiscal 2026 Financial Results
17 hours ago

Biomerica Reports Third Quarter Fiscal 2026 Financial Results

Indeterminate GlobeNewswire
Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support
17 hours ago

Clean Eye Claims Evaluated: The CleanEye Vision Care Capsules for Retina Clear Visual Support

Indeterminate GlobeNewswire
Ballad Health’s program for assisting uninsured patients earns national award for its community-based approach to serving rural Appalachia
18 hours ago

Ballad Health’s program for assisting uninsured patients earns national award for its community-based approach to serving rural Appalachia

Indeterminate GlobeNewswire
AIM ImmunoTech Provides Routine Update on Annual Filings
18 hours ago

AIM ImmunoTech Provides Routine Update on Annual Filings

Indeterminate GlobeNewswire
XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset
Apr. 13, 2026

XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
Apr. 13, 2026

Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Indeterminate GlobeNewswire
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
Apr. 13, 2026

ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors

Indeterminate GlobeNewswire
BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference
Apr. 13, 2026

BioAge Labs to Present at 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform
Apr. 13, 2026

Cema-Cel Pivotal Trial Interim Data Highlight Strength of Cellectis’ Allogeneic CAR-T Platform

Indeterminate GlobeNewswire
Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis
Apr. 13, 2026

Les données intermédiaires de l'essai pivot testant cema-cel mettent en évidence la solidité de la plateforme CAR-T allogénique de Cellectis

Indeterminate GlobeNewswire
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
Apr. 13, 2026

Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451

Indeterminate GlobeNewswire
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Apr. 13, 2026

BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Celldex to Present at Upcoming Investor Conference
Apr. 13, 2026

Celldex to Present at Upcoming Investor Conference

Indeterminate GlobeNewswire
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
Apr. 13, 2026

Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes

Indeterminate GlobeNewswire
Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock
Apr. 13, 2026

Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock

Indeterminate GlobeNewswire
Celebrating National Medical Laboratory Week
Apr. 13, 2026

Celebrating National Medical Laboratory Week

Indeterminate GlobeNewswire
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
Apr. 13, 2026

Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group

Indeterminate GlobeNewswire
Vital Hemp Gummies | Launch" Hemp Gummies Australia, NZ Or Canada Relieves Anxiety Effective Reduces Pain Relax Stress With Vital Hemp 2026
Apr. 13, 2026

Vital Hemp Gummies | Launch" Hemp Gummies Australia, NZ Or Canada Relieves Anxiety Effective Reduces Pain Relax Stress With Vital Hemp 2026

Indeterminate GlobeNewswire
Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand
Apr. 13, 2026

Dermatology Devices Market to Reach $25.6 Billion by 2030, Driven by Rising Skin Cancer Incidence and Aesthetic Demand

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions